
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1100 | 1039 | 1080 | 1440 | 1711 | 1702 |
Fund Return | 9.98% | 3.89% | 7.95% | 12.92% | 11.34% | 5.46% |
Place in category | 400 | 533 | 665 | 480 | 371 | 462 |
% in Category | 16 | 23 | 31 | 24 | 23 | 46 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AllianzIncome Growth AT H2EUR | 45.17B | 3.04 | 8.46 | 4.87 | ||
Allianz Income and Growth P EUR | 45.17B | -7.30 | 7.31 | 7.08 | ||
AllianzIncome Growth RM H2EUR | 45.17B | 3.23 | 8.99 | - | ||
AllianzIncome Growth AM H2EUR | 45.17B | 3.04 | 8.50 | 4.89 | ||
AllianzIncome Growth P H2EUR | 45.17B | 3.35 | 9.07 | 5.53 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund E Acc EUR | 7.56B | 6.36 | 11.98 | 4.10 | ||
European Growth Fund Y Acc EUR | 160.27M | 7.23 | 13.78 | 5.75 | ||
European Growth Fund Y DIST EUR | 7.56B | 7.24 | 13.78 | 5.76 | ||
European Growth Fund A DIST Eue | 7.56B | 6.76 | 12.81 | 4.88 | ||
European Growth Fund A Acc EUR | 176.81M | 6.78 | 12.84 | 4.88 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Allianz Eurp Eq pwrd by Artfcl IntlgcWT€ | LU2397364675 | 7.92 | - | - | |
SAP | DE0007164600 | 2.48 | 258.750 | -1.65% | |
ASML Holding | NL0010273215 | 2.39 | 683.90 | -0.88% | |
Novartis | CH0012005267 | 2.18 | 96.23 | -3.00% | |
Roche Holding Participation | CH0012032048 | 2.13 | 256.80 | -2.36% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review